European Journal of Cancer

Energy balance, cancer and the sympathetic nervous system
pp. 289-292(4)
Authors: Harvie M.N.; Campbell I.T.

Do we need better prognostic factors in node-negative breast cancer? - Pro:
pp. 293-298(6)
Authors: Thomssen C.; Janicke F.

Do we need better prognostic factors in nodal-negative breast cancer? - Contra:
pp. 298-301(4)
Authors: Kaufmann M.; Scharl A.

Do we need prognostic factors in nodal-negative breast cancer? - Arbiter:
pp. 302-306(5)
Author: Hayes D.F.

Evaluation of the carcinogenic risks to humans associated with surgical implants and other foreign bodies - a report of an IARC Monographs Programme Meeting
pp. 307-313(7)
Authors: McGregor D.B.; Baan R.A.; Partensky C.; Rice J.M.; Wilbourn J.D.

Cancer chemoprevention through interruption of multistage carcinogenesis - the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer
pp. 314-329(16)
Authors: Marks F.; Furstenberger G.

-Adrenoceptor activity and resting energy metabolism in weight losing cancer patients
pp. 330-334(5)
Authors: Hyltander A.; Daneryd P.; Sandstrom R.; Korner U.; Lundholm K.

Low alpha-linolenic acid content of adipose breast tissue is associated with an increased risk of breast cancer
pp. 335-340(6)
Authors: Klein V.; Chajes V.; Germain E.; Schulgen G.; Pinault M.; Malvy D.; Lefrancq T.; Fignon A.; Le Floch O.; Lhuillery C.; Bougnoux P.

Chronotherapy with 5-fluorouracil, folinic acid and carboplatin for metastatic colorectal cancer; an interesting therapeutic index in a phase II trial
pp. 341-347(7)
Authors: Focan C.; Kreutz F.; Focan-Henrard D.; Moeneclaey N.

p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer
pp. 348-356(9)
Authors: Schwandner O.; Schiedeck T.H.K.; Bruch H.-P.; Duchrow M.; Windhoevel U.; Broll R.

Prognostic value of the expression of E-cadherin and -catenin in bladder cancer
pp. 357-362(6)
Authors: Garcia del Muro X.; Torregrosa A.; Munoz J.; Castellsague X.; Condom E.; Vigues F.; Arance A.; Fabra A.; Germa J.R.

Weekly alternating combination chemotherapy for good prognosis AIDS-related lymphoma
pp. 363-367(5)
Authors: Bower M.; Stern S.; Fife K.; Nelson M.; Gazzard B.G.

Bone marrow transplantation for children with acute myelogenous leukaemia in the first complete remission
pp. 368-375(8)
Authors: Matsuyama T.; Horibe K.; Kato K.; Kojima S.S.

Non-seminomatous ovarian germ cell tumours in children
pp. 376-383(8)
Authors: Baranzelli M.C.; Bouffet E.; Quintana E.; Portas M.; Thyss A.; Patte C.

Long-term survival in Hodgkin's disease patients - a comparison of relative survival in patients in trials and those recorded in population-based cancer registries
pp. 384-389(6)
Authors: Roy P.; Vaughan Hudson G.; Vaughan Hudson B.; Esteve J.; Swerdlow A.J.

Prognostic factors after curative resection for gastric cancer. A population-based study
pp. 390-396(7)
Authors: Msika S.; Benhamiche A.M.; Jouve J.-L.; Rat P.; Faivre J.

An antisense oligonucleotide targeting the V integrin gene inhibits adhesion and induces apoptosis in breast cancer cells
pp. 397-409(13)
Authors: Townsend P.A.; Villanova I.; Uhlmann E.; Peyman A.; Knolle J.; Baron R.; Teti A.; Horton M.A.

In vitro and in vivo effects of a cyclic peptide with affinity for the 3 integrin in human melanoma cells
pp. 410-422(13)
Authors: Allman R.; Cowburn P.; Mason M.

Effect of 1-linolenyl-3-eicosapentaenoyl propane diol on the growth of human pancreatic carcinoma in vitro and in vivo
pp. 423-427(5)
Authors: Ravichandran D.; Cooper A.; Johnson C.D.

Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein
pp. 428-434(7)
Authors: Benderra Z.; Trussardi A.; Morjani H.; Villa A.M.; Doglia S.M.; Manfait M.